---
figid: PMC9503112__ijms-23-10854-g001
pmcid: PMC9503112
image_filename: ijms-23-10854-g001.jpg
figure_link: /pmc/articles/PMC9503112/figure/ijms-23-10854-f001/
number: Figure 1
figure_title: ''
caption: FDA-approved inhibitors of PI3K/Akt/mTOR pathway [,,].
article_title: Synthesis, Molecular Docking, In Vitro and In Vivo Studies of Novel
  Dimorpholinoquinazoline-Based Potential Inhibitors of PI3K/Akt/mTOR Pathway.
citation: Maria V. Zapevalova, et al. Int J Mol Sci. 2022 Sep;23(18):10854.
year: '2022'

doi: 10.3390/ijms231810854
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI

keywords:
- dimorpholinoquinazoline
- cancer
- PI3K/Akt/mTOR inhibitor
- S6K
- kinase inhibition activity

---
